The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Cyclodextrins as pharmaceutical solubilizers
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Comprehensive supramolecular chemistry
(1997) · Choice Reviews Online · doi:10.5860/choice.34-5097 · Cited by 6,476
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, T., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,176
Self-citationThe Stability of Cyclodextrin Complexes in Solution
Connors, K. A. (1997) · Chemical Reviews · doi:10.1021/cr960371r · Cited by 2,175
Cyclodextrin Drug Carrier Systems
Uekama, K., Hirayama, F., & Irie, T. (1998) · Chemical Reviews · doi:10.1021/cr970025p · Cited by 2,145
Cyclodextrin-based pharmaceutics: past, present and future
Davis, M. E., & Brewster, M. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1576 · Cited by 1,996
Self-citationBender, M. L., & Komiyama, M. (1978) · Reactivity and Structure Concepts in Organic Chemistry · doi:10.1007/978-3-642-66842-5 · Cited by 1,893
Cyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Self-citationSzejtli, J. (1988) · Topics in Inclusion Science · doi:10.1007/978-94-015-7797-7 · Cited by 1,759
Solubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
Cyclodextrins and their inclusion complexes
Smolková-Keulemansová, E. (1982) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)88372-2 · Cited by 1,252
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Surfactant Science and Technology
Myers, D. (2020) · Wiley eBooks · doi:10.1002/9781119465829 · Cited by 1,074
Cyclodextrins and their inclusion complexes
Szejtli, J. (1982) · REAL-EOD (Library of the Hungarian Academy of Sciences and the Information Center Oriental Collection) · Cited by 970
Clarke's analysis of drugs and poisons
Moffat, A., Osselton, M. D., & Widdop, B. (2003) · Pharmaceutical Press eBooks · Cited by 941
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
Irie, T., & Uekama, K. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960213f · Cited by 924
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
Rajewski, R. A., & Stella, V. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960075u · Cited by 824
Cyclodextrins in drug delivery
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.335 · Cited by 793
Self-citation2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications
(2006) · Wiley eBooks · doi:10.1002/3527608982 · Cited by 728
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
Frömming, K.-H., & Szejtli, J. (1994) · Topics in Inclusion Science · doi:10.1007/978-94-015-8277-3 · Cited by 658
Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions
Yu, L. X., Amidon, G. L., Polli, J. E., Zhao, H., Mehta, M. U., Conner, D. P., Shah, V. P., Lesko, L. J., Chen, M.-L., Lee, V. H. L., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1016473601633 · Cited by 571
Martin'S Physical Pharmacy And Pharmaceutical Sciences
Sinko (2008) · Cited by 520
Cyclodextrin-based controlled drug release system
Hirayama, F. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00058-1 · Cited by 494
Pharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
Mechanisms of drug release from cyclodextrin complexes
Stella, V. J., Rao, V. M., Zannou, E. A., & Zia, V. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00052-0 · Cited by 442
Self-Association of Cyclodextrins and Cyclodextrin Complexes
Loftsson, T., Másson, M., & Brewster, M. E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20047 · Cited by 426
Self-citationCyclodextrinsEnabling Excipients: Their Present and Future Use in Pharmaceuticals
Thompson, D. O. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i1.10 · Cited by 421
Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins
SZEJTLI, J., & SZENTE, L. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.006 · Cited by 379
Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems
Rodríguez‐hornedo, N., & Murphy, D. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980490h · Cited by 371
Surfactant science and technology
Becher, P. (1989) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(89)90107-0 · Cited by 370
Design and Evaluation of Cyclodextrin-Based Drug Formulation
Uekama, K. (2004) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.52.900 · Cited by 356
Surfactants and Polymers in Drug Delivery
(2002) · CRC Press eBooks · doi:10.1201/9780824743758 · Cited by 299
Role of Cyclodextrins in Improving Oral Drug Delivery
Loftsson, T., Brewster, M. E., & M??sson, M. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00006 · Cited by 287
Self-citationSelf‐Association and Cyclodextrin Solubilization of Drugs
Loftsson, T., Magnúsdóttir, A., Másson, M., & Sigurjónsdóttir, J. F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10226 · Cited by 277
Self-citationPeeters, J., Neeskens, P., Tollenaere, J. P., Van Remoortere, P., & Brewster, M. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10126 · Cited by 272
Self-citationGao, P., Guyton, M. E., Huang, T., Bauer, J. M., Stefanski, K. J., & Lu, Q. (2004) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120028718 · Cited by 208
Population Characteristics of Cyclodextrin Complex Stabilities in Aqueous Solution
Connors, K. A. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840712 · Cited by 188
Physicochemical and Structural Characterization of Quercetin-β-Cyclodextrin Complexes
Zheng, Y., Haworth, I. S., Zuo, Z., Chow, M. S. S., & Chow, A. H. L. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20325 · Cited by 187
New trends in cyclodextrins and derivatives
Duchêne, D. (1991) · Cited by 182
Inhibition of Sulfathiazole Crystal Growth by Polyvinylpyrrolidone
Simonelli, A. P., Mehta, S. C., & Higuchi, W. I. (1970) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600590512 · Cited by 177
Binding mechanisms in cyclohexaamylose complexes
Gelb, R. I., Schwartz, L. M., Cardelino, B. H., Fuhrman, H. S., Johnson, R. F., & Laufer, D. A. (1981) · Journal of the American Chemical Society · doi:10.1021/ja00397a027 · Cited by 156
Drug/Cyclodextrin/Hydroxy Acid Multicomponent Systems. Properties and Pharmaceutical Applications
Redenti, E., Szente, L., & Szejtli, J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200001)89:1<1::aid-jps1>3.0.co;2-w · Cited by 154
Larsen, K. L. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1020494503684 · Cited by 150
Water-Insoluble Drug Formulation, Third Edition
(2018) · CRC Press eBooks · doi:10.1201/9781315120492 · Cited by 144
Phase solubility studies of pure (−)-α-bisabolol and camomile essential oil with β-cyclodextrin
Waleczek, K. J. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00166-2 · Cited by 137
Sinha, V. R., Anitha, R., Ghosh, S., Nanda, A., & Kumria, R. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20287 · Cited by 137
Nondestructive and on-line monitoring of tablets using light-induced fluorescence technology
Lai, C. K., Zahari, A., Miller, B., et al. (2004) · AAPS PharmSciTech · doi:10.1208/pt050103 · Cited by 135
Cyclodextrin glycosyltransferase production: yield enhancement by overexpression of cloned genes
SCHMID, G. (1989) · Trends in biotechnology · doi:10.1016/0167-7799(89)90015-2 · Cited by 132
Redenti, E., Szente, L., & Szejtli, J. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1050 · Cited by 123
Cyclodextrins and the Biopharmaceutics Classification System of Drugs
Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023088423667 · Cited by 121
Water-Insoluble Drug Formulation
Ron, L. (2000) · CRC Press eBooks · doi:10.1201/9781420026054 · Cited by 119
Calabrò, M., Tommasini, S., Donato, P., Raneri, D., Stancanelli, R., Ficarra, P., Ficarra, R., Costa, C., Catania, S., Rustichelli, C., et al. (2004) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2003.12.005 · Cited by 118
Cyclodextrins and their complexes: Chemistry, analytical methods, applications
Holmes, A. E. (2006) · Chirality · doi:10.1002/chir.20351 · Cited by 117
Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids
Mura, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00265-5 · Cited by 116
On the specificity of cyclodextrin complexes detected by electrospray mass spectrometry
Gabelica, V., Galić, N., & Pauw, E. D. (2002) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(02)00416-6 · Cited by 116
Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes
Pinto, L. D. M. A., Fraceto, L. F., Santana, M. H. A., Pertinhez, T. A., Oyama, S., & de Paula, E. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.06.010 · Cited by 111
Inclusion complexes of carotenoids with cyclodextrins: 1HNMR, EPR, and optical studies
Polyakov, N. E., Leshina, T. V., Konovalova, T. A., Hand, E. O., & Kispert, L. D. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.12.009 · Cited by 111
Proceedings of the Fourth International Symposium on Cyclodextrins
Huber, O., & Szejtli, J. (1988) · Springer eBooks · doi:10.1007/978-94-009-2637-0 · Cited by 109
Liu, L., & Guo, Q. (1999) · The Journal of Physical Chemistry B · doi:10.1021/jp984545f · Cited by 108
Correia, I., Bezzenine, N., Ronzani, N., Platzer, N., Belœil, J., & Doan, B. (2002) · Journal of Physical Organic Chemistry · doi:10.1002/poc.528 · Cited by 106
Self Association and Cyclodextrin Solubilization of NSAIDs
Magnusdottir, A., Másson, M., & Loftsson, Þ. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023079322024 · Cited by 99
Yap, K. L., Liu, X., Thenmozhiyal, J. C., et al. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.01.021 · Cited by 98
When can cyclodextrins be considered for solubilization purposes?
Rao, V. M., & Stella, V. J. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10341 · Cited by 93
Tommasini, S., Calabrò, M., Stancanelli, R., Donato, P., Costa, C., Catania, S., Villari, V., Ficarra, P., & Ficarra, R. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.05.009 · Cited by 91
Preparation and Characterization of Albendazole β-Cyclodextrin Complexes
Castillo, J. A., Palomo-Canales, J., Garcia, J. J., Lastres, J. L., Bolás-Fernández, F., & Torrado, J. J. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102294 · Cited by 89
Formation of Natamycin:Cyclodextrin Inclusion Complexes and Their Characterization
Koontz, J. L., & Marcy, J. E. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf030332y · Cited by 86
Recent Aspect of Cyclodextrin-Based Drug Delivery System
Uekama, K., Hirayama, F., & Arima, H. (2006) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-006-9052-y · Cited by 86
Figueiras, A., Sarraguça, J. M. G., Carvalho, R. A., Pais, A. A. C. C., & Veiga, F. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9161-8 · Cited by 83
β-Cyclodextrin: 52-Week toxicity studies in the rat and dog
Bellringer, M. E., Smith, T., Read, R. C., Gopinath, C., & Olivier, P. (1995) · Food and Chemical Toxicology · doi:10.1016/0278-6915(94)00149-i · Cited by 81
Pitha, J., & Hoshino, T. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90281-6 · Cited by 80
Cyclodextrin/imatinib complexation: Binding mode and charge dependent stabilities
Béni, S., Szakács, Z., Csernák, O., Barcza, L., & Noszál, B. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.10.008 · Cited by 72
Tomasik, P., & Schilling, C. H. (1998) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/s0065-2318(08)60047-5 · Cited by 66
Molecular Electrostatic Potentials and Hydrogen Bonding in α-, β-, and γ-Cyclodextrins
Pinjari, R. V., Joshi, K. A., & Gejji, S. P. (2006) · The Journal of Physical Chemistry A · doi:10.1021/jp065169z · Cited by 61
Solubility and Dissolution Rate of Progesterone-Cyclodextrin-Polymer Systems
Lahiani‐Skiba, M., Barbot, C., Bounoure, F., Joudieh, S., & Skiba, M. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040600897093 · Cited by 61
Loftsson, Þ., Össurardóttir, Í. B., Thorsteinsson, T., Duan, M., & Másson, M. (2005) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1007/s10847-004-6048-3 · Cited by 60
Preparation of solid drug/cyclodextrin complexes of acidic and basic drugs.
Loftsson, Þ., Sigurðsson, H. H., Másson, M., & Schipper, N. G. M. (2004) · PubMed · Cited by 57
Jacobsen, J., Bjerregaard, S., & Pedersen, M. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00043-0 · Cited by 57
Subchronic oral toxicity studies with α-cyclodextrin in rats
Lina, B. A. R., & Bär, A. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.05.006 · Cited by 55
Disposition of [14C]γ-Cyclodextrin in Germ-Free and Conventional Rats
de Bie, A. T. H. J., van Ommen, B., & Bär, A. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1998.1219 · Cited by 53
The effect of β-cyclodextrins on the permeation of diclofenac from supersaturated solutions
Dias, M. M. R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00366-1 · Cited by 50
Brewster, M. E., Loftsson, Þ., Estes, K. S., Lin, J.-L., Friđriksdóttir, H., & Bodor, N. S. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90121-h · Cited by 49
Self-citationTorres-Labandeira, J. J., Davignon, P., & Pitha, J. (1991) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600800421 · Cited by 49
Study of the interaction between S(−) bupivacaine and 2-hydroxypropyl-β-cyclodextrin
Moraes, C. M., Abrami, P., DEPAULA, E., Braga, A. A. C., & Fraceto, L. F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.054 · Cited by 48
Loukas, Y. L. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06021.x · Cited by 48
Solubility Enhancers for Oral Drug Delivery
Kim, C., & Park, J. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402020-00004 · Cited by 46
Subchronic (13-week) oral toxicity study of α-cyclodextrin in dogs
Lina, B. A. R., & Bär, A. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.05.005 · Cited by 44
Ventura, C. A., Giannone, I., Musumeci, T., Pignatello, R., Ragni, L., Landolfi, C., Milanese, C., Paolino, D., & Puglisi, G. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.11.002 · Cited by 42
Disposition of 14C-α-cyclodextrin in germ-free and conventional rats
van Ommen, B., de Bie, A. T. H. J., & Bär, A. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.05.011 · Cited by 40
Synthesis of Large-Ring Cyclodextrins by Cyclodextrin Glucanotransferases from Bacterial Isolates
Zheng, M., Endo, T., & Zimmermann, W. (2002) · Journal of Inclusion Phenomena and Macrocyclic Chemistry · doi:10.1023/a:1023056911372 · Cited by 36
Ueda, H., & Endo, T. (2006) · doi:10.1002/3527608982.ch13 · Cited by 32
ChemInform Abstract: CYCLOAMYLOSE‐SUBSTRATE BINDING
Bergeron, R. J. (1985) · ChemInform · doi:10.1002/chin.198537356 · Cited by 28
Pedersen, M., Bjerregaard, S., Jacobsen, J., Larsen, A. R., & Sørensen, A. M. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00431-6 · Cited by 27
Gastrointestinal tolerance of γ-cyclodextrin in humans
Koutsou, G. A., Storey, D. M., & Bär, A. (1999) · Food Additives & Contaminants · doi:10.1080/026520399283984 · Cited by 27
Brewster, M. E., Mackie, C. E., Noppe, M., Lampo, A., & Loftsson, Þ. (2007) · Springer eBooks · doi:10.1007/978-0-387-69154-1_8 · Cited by 21
Self-citationInjectable Drug Development: Techniques to Reduce Pain and Irritation
(1999) · CRC Press eBooks · doi:10.1201/b14378 · Cited by 18
Holvoet, C. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00368-5 · Cited by 17
Complexation—Use of Cyclodextrins to Improve Pharmaceutical Properties of Intramuscular Formulations
Brewster, M. E., & Loftsson, Þ. (1999) · CRC Press eBooks · doi:10.1201/b14378-17 · Cited by 14
Self-citation
Cited by
Review: A History of Cyclodextrins
Crini, G. (2014) · Chemical Reviews · doi:10.1021/cr500081p · Cited by 1,906
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Biomedical Applications of Supramolecular Systems Based on Host–Guest Interactions
Ma, X., & Zhao, Y. (2015) · Chemical Reviews · doi:10.1021/cr500392w · Cited by 1,225
Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., & Onoue, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.032 · Cited by 1,181
Pharmaceutical applications of cyclodextrins: basic science and product development
Loftsson, T., & Brewster, M. E. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01030.x · Cited by 1,031
Self-citation
Metadata
- Authors
- Brewster, M. E., & Loftsson, T.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 59
- Issue
- 7
- Pages
- 645-666
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2074582913
- Cited by
- 1,882
- References
- 103
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.